KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Average Pmpm By Product TypeAverage Pmpm Fees / Revenue Per Case By SegmentAverage Unique MembersAverage Unique Members AnnualAverage Yield Per CaseBreakdown Of AssetsContractual ObligationsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionLives By Product TypeLives Managed By SegmentLives On Platform/ Cases During Period By SegmentNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, NetRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By End MarketRevenue By End Market %Revenue By End Market AnnualRevenue By End Market Annual %Revenue By Product TypeRevenue By Product Type %Revenue By Product Type AnnualRevenue By Product Type Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Cases ManagedTotal Lives ManagedTotal Lives On Platform
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Cost Of Revenue (2016 - 2025)

Historic Cost of Revenue for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $379.8 million.

  • Evolent Health's Cost of Revenue fell 2976.63% to $379.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 1908.63%. This contributed to the annual value of $2.2 billion for FY2024, which is 4549.36% up from last year.
  • Per Evolent Health's latest filing, its Cost of Revenue stood at $379.8 million for Q3 2025, which was down 2976.63% from $343.9 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Cost of Revenue ranged from a high of $570.8 million in Q4 2024 and a low of $157.8 million during Q1 2021
  • In the last 5 years, Evolent Health's Cost of Revenue had a median value of $343.9 million in 2025 and averaged $341.5 million.
  • In the last 5 years, Evolent Health's Cost of Revenue surged by 8200.88% in 2022 and then tumbled by 3634.25% in 2025.
  • Evolent Health's Cost of Revenue (Quarter) stood at $164.5 million in 2021, then skyrocketed by 82.01% to $299.4 million in 2022, then surged by 51.8% to $454.4 million in 2023, then grew by 25.62% to $570.8 million in 2024, then plummeted by 33.47% to $379.8 million in 2025.
  • Its Cost of Revenue stands at $379.8 million for Q3 2025, versus $343.9 million for Q2 2025 and $381.2 million for Q1 2025.